Regulatorische Updates
27. Sept. 2026•1 Min. Lesezeit
FDA Approves ANDA079186 for Dorzolamide Hydrochloride Ophthalmic Solution
FDA granted approval for ANDA079186, a generic Dorzolamide Hydrochloride ophthalmic solution submitted by AM Regent, with original approval in 2009 and a labeling supplement in 2020.
Regulatorische Updates
26. Aug. 2026•1 Min. Lesezeit
FDA Approves ANDA078395 for Dorzolamide Hydrochloride Ophthalmic Solution
The FDA has approved ANDA078395 for a 2% Dorzolamide Hydrochloride ophthalmic solution marketed by Advagen Pharma Ltd., with Rubicon Research as sponsor.